tiprankstipranks
Trending News
More News >
Nuvalent (NUVL)
NASDAQ:NUVL
US Market

Compare Nuvalent (NUVL) vs. Competitors

Compare
159 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Nuvalent
$102.89
$7.48B
-19.35
17.25%
16 Buy
0 Hold
0 Sell
Strong Buy
Cytokinetics
$63.19
$7.73B
-10.02
26.46%
14 Buy
2 Hold
0 Sell
Strong Buy
TG Therapeutics
$29.43
$4.67B
10.59
-11.78%
3 Buy
1 Hold
1 Sell
Moderate Buy
Axsome Therapeutics
$184.25
$9.29B
-39.43
69.27%
14 Buy
1 Hold
0 Sell
Strong Buy
Avidity Biosciences
$72.57
$10.94B
-17.40
122.40%
2 Buy
8 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NUVL
Nuvalent
102.89
18.04
21.26%
CYTK
Cytokinetics
63.19
14.73
30.40%
TGTX
TG Therapeutics
29.43
-2.05
-6.51%
AXSM
Axsome Therapeutics
184.25
76.82
71.51%
MRUS
RNA
Avidity Biosciences
72.57
40.61
127.07%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts